Treace Medical Concepts (TMCI) Competitors $7.07 -0.15 (-2.08%) Closing price 04:00 PM EasternExtended Trading$7.08 +0.00 (+0.07%) As of 07:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TMCI vs. CNMD, NVCR, SSII, CDRE, BLFS, ESTA, MDXG, PLSE, INMD, and IRMDShould you be buying Treace Medical Concepts stock or one of its competitors? The main competitors of Treace Medical Concepts include CONMED (CNMD), NovoCure (NVCR), SS Innovations International (SSII), Cadre (CDRE), BioLife Solutions (BLFS), Establishment Labs (ESTA), MiMedx Group (MDXG), Pulse Biosciences (PLSE), InMode (INMD), and iRadimed (IRMD). These companies are all part of the "medical equipment" industry. Treace Medical Concepts vs. Its Competitors CONMED NovoCure SS Innovations International Cadre BioLife Solutions Establishment Labs MiMedx Group Pulse Biosciences InMode iRadimed Treace Medical Concepts (NASDAQ:TMCI) and CONMED (NYSE:CNMD) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, valuation, analyst recommendations, profitability, media sentiment and earnings. Is TMCI or CNMD more profitable? CONMED has a net margin of 8.31% compared to Treace Medical Concepts' net margin of -23.01%. CONMED's return on equity of 14.43% beat Treace Medical Concepts' return on equity.Company Net Margins Return on Equity Return on Assets Treace Medical Concepts-23.01% -46.76% -23.35% CONMED 8.31%14.43%6.05% Does the media favor TMCI or CNMD? In the previous week, CONMED had 3 more articles in the media than Treace Medical Concepts. MarketBeat recorded 7 mentions for CONMED and 4 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 0.92 beat CONMED's score of 0.55 indicating that Treace Medical Concepts is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Treace Medical Concepts 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CONMED 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend TMCI or CNMD? Treace Medical Concepts currently has a consensus price target of $9.83, indicating a potential upside of 39.09%. CONMED has a consensus price target of $59.80, indicating a potential upside of 13.41%. Given Treace Medical Concepts' stronger consensus rating and higher possible upside, equities research analysts clearly believe Treace Medical Concepts is more favorable than CONMED.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Treace Medical Concepts 0 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33CONMED 0 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.20 Which has better valuation & earnings, TMCI or CNMD? CONMED has higher revenue and earnings than Treace Medical Concepts. Treace Medical Concepts is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTreace Medical Concepts$209.36M2.13-$55.74M-$0.79-8.95CONMED$1.31B1.25$132.42M$3.5314.94 Which has more volatility & risk, TMCI or CNMD? Treace Medical Concepts has a beta of 0.71, indicating that its share price is 29% less volatile than the S&P 500. Comparatively, CONMED has a beta of 1.18, indicating that its share price is 18% more volatile than the S&P 500. Do institutionals & insiders have more ownership in TMCI or CNMD? 84.1% of Treace Medical Concepts shares are owned by institutional investors. 27.7% of Treace Medical Concepts shares are owned by company insiders. Comparatively, 3.1% of CONMED shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. SummaryCONMED beats Treace Medical Concepts on 8 of the 15 factors compared between the two stocks. Get Treace Medical Concepts News Delivered to You Automatically Sign up to receive the latest news and ratings for TMCI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TMCI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TMCI vs. The Competition Export to ExcelMetricTreace Medical ConceptsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$456.11M$6.65B$5.69B$10.27BDividend YieldN/A1.21%5.72%4.60%P/E RatioN/A26.6075.8626.51Price / Sales2.13193.66489.92165.26Price / CashN/A22.1825.8129.89Price / Book3.914.9512.846.32Net Income-$55.74M$176.38M$3.28B$270.51M7 Day Performance-4.46%4.79%0.22%2.15%1 Month Performance2.61%7.07%4.61%6.35%1 Year Performance41.12%10.43%68.33%25.48% Treace Medical Concepts Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TMCITreace Medical Concepts2.378 of 5 stars$7.07-2.1%$9.83+39.1%+41.0%$446.61M$209.36M-8.95250CNMDCONMED4.2229 of 5 stars$53.78-2.2%$59.80+11.2%-31.3%$1.70B$1.31B15.233,900Insider TradeNVCRNovoCure4.2612 of 5 stars$12.60+2.6%$28.79+128.5%-31.5%$1.37B$605.22M-8.081,488News CoveragePositive NewsGap UpSSIISS Innovations InternationalN/A$6.14-12.3%N/AN/A$1.36B$20.65M0.004News CoverageGap DownHigh Trading VolumeCDRECadre2.8317 of 5 stars$31.83-0.5%$31.50-1.0%-8.5%$1.30B$567.56M33.862,284Positive NewsAnalyst UpgradeBLFSBioLife Solutions2.5796 of 5 stars$26.22-0.9%$31.29+19.3%+2.7%$1.27B$93.47M-218.48440Trending NewsESTAEstablishment Labs2.2868 of 5 stars$38.24-2.0%$56.50+47.8%-16.7%$1.13B$166.02M-12.541,018Positive NewsMDXGMiMedx Group3.4971 of 5 stars$7.17+0.4%$12.00+67.4%+12.1%$1.06B$348.88M34.14870Positive NewsPLSEPulse Biosciences4.2363 of 5 stars$15.04-0.5%$22.00+46.3%-15.0%$1.02B$700K-14.32140News CoveragePositive NewsInsider TradeINMDInMode2.8772 of 5 stars$15.28+2.0%$18.04+18.1%-12.8%$946.87M$401.56M6.19480Positive NewsIRMDiRadimed4.8036 of 5 stars$71.85-0.2%$72.00+0.2%+47.7%$915.36M$73.24M44.35110Positive NewsShort Interest ↓ Related Companies and Tools Related Companies CONMED Alternatives NovoCure Alternatives SS Innovations International Alternatives Cadre Alternatives BioLife Solutions Alternatives Establishment Labs Alternatives MiMedx Group Alternatives Pulse Biosciences Alternatives InMode Alternatives iRadimed Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TMCI) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersFanatics Hit $31B-Is This Nasdaq Next?Fanatics built an empire by owning the fan experience-scaling to a $31B valuation. But the next wave isn't abo...i2i Marketing Group, LLC | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredOpenAI’s new $300 billion dealOpenAI just signed a $300 billion cloud deal with Oracle to secure the computing power needed for its next Cha...Porter & Company | SponsoredNew Buy Alert: Should you put $1,000 into Oracle (ORCL) now?Barron's is calling this Oracle's "Nvidia Moment..." While the Wall Street Journal is simply calling Oracle...Chaikin Analytics | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Treace Medical Concepts, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Treace Medical Concepts With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TMCI Stock Alerts